Augmedix

Augmedix EBIT Margin

Delisted

The EBIT Margin (Operating Margin) of Augmedix (AUGX) as of Oct 12, 2026 is -41.87 %. In the previous year, EBIT Margin (Operating Margin) was -72.32 % — a change of -42.11% (higher).

EBIT Margin

-41.87 %

YoY

-42.11%

Last updated:

EBIT Margin (Operating Margin) of Augmedix is 2023 -41.87 % . EBIT Margin (Operating Margin) of Augmedix was 2022 -72.32 % . It decreases by -42.11% higher compared to the previous year.

Augmedix's operating (EBIT) margin stands at -41.9%, up from -118.7% several years earlier.

The Augmedix EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
-118.68 USD
Jan 1, 2020
-83.07 USD
Jan 1, 2021
-80.93 USD
Jan 1, 2022
-72.32 USD
Jan 1, 2023
-41.87 USD
The Augmedix EBIT Margin history
YEAREBIT MarginYoY
-41.87 %-42.11%
-72.32 %-10.64%
-80.93 %-2.58%
-83.07 %-30.00%
-118.68 %—
Access this data via the Eulerpool API

Augmedix Stock analysis

What does Augmedix do? Augmedix Inc. is a San Francisco-based company specializing in the development of technologies and software to assist medical professionals. It was founded in 2012 by Ian Shakil and Pelu Tran to change the way doctors capture and document patient data. The decision to start Augmedix was influenced by the personal experiences of the two founders. While working in the emergency room, Shakil noticed that he was constantly turning his back on his patients to create medical records, which took away from the actual treatment and interrupted visual contact with the patient. Based on his experiences, he saw an opportunity to help doctors focus more on their patients. Pelu Tran, the other founder, also worked in the healthcare industry and wanted to help doctors and nurses have more time for patient care. Augmedix's business model is based on the integration of speech technology and virtual reality. Augmedix has developed specialized software that directs doctors' attention away from data entry and towards treating their patients. Instead of focusing on writing notes, dictation, and clarifying paper notes, doctors can speak directly to a virtual assistant in real-time, who automates their records and embeds them into their medical records. Through this process automation, doctors can spend more time caring for their patients. Augmedix has now specialized in various areas within medical technology. For example, Augmedix offers speech technology platforms that surgical teams can use to access patient information and follow care protocols during surgery without leaving the operating table. There are also wireless mobile headsets that allow doctors to access patient information and create notes during patient treatment without interrupting contact between the doctor and patient. Augmedix also offers a telemedicine telepresence system that allows doctors and patients to communicate with each other via video calls. The system provides a convenient way for both patients and doctors to conduct and receive video consultations without the need for physical presence. Augmedix has become a major player in the digital healthcare industry, especially for doctors and hospitals. The company has already gained many customers in the US healthcare sector, including dozens of leading clinic chains. With its unique business model, Augmedix has taken a pioneering role in introducing new technologies in healthcare. In collaboration with the cloud computing platform Google Cloud, a dedicated medical security cloud platform and application for the healthcare industry are now being developed. Augmedix and Google Cloud now enable doctors to send medical data in real-time to their Augmedix virtual assistant and simultaneously update existing HIPAA-compliant patient records. Overall, Augmedix has become an important company for the introduction of new technologies in healthcare and can be proud to support doctors in their work and optimize healthcare for patients. Augmedix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Augmedix stock

EBIT Margin (Operating Margin) of Augmedix is -41.87 % in 2023.

EBIT Margin (Operating Margin) of Augmedix changed from -72.32 % to -41.87 %, representing a -42.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Augmedix since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Augmedix with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

Margins — Augmedix

All Key Metrics — Augmedix